HMGCS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.378800E-01
Normal-vs-Stage2
8.863200E-01
Normal-vs-Stage3
5.810800E-01
Normal-vs-Stage4
8.941000E-01
Stage1-vs-Stage2
9.587400E-01
Stage1-vs-Stage3
6.959000E-01
Stage1-vs-Stage4
8.331400E-01
Stage2-vs-Stage3
6.355400E-01
Stage2-vs-Stage4
7.444000E-01
Stage3-vs-Stage4
4.271600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.828600E-01
Normal-vs-AfricanAmerican
7.242800E-01
Normal-vs-Asian
7.516200E-01
Caucasian-vs-AfricanAmerican
9.728800E-01
Caucasian-vs-Asian
2.300600E-01
AfricanAmerican-vs-Asian
4.186600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.211400E-01
Normal-vs-Female
8.078800E-01
Male-vs-Female
8.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.555000E-01
Normal-vs-Age(41-60Yrs)
7.812000E-01
Normal-vs-Age(61-80Yrs)
8.745200E-01
Normal-vs-Age(81-100Yrs)
5.501600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.362000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.119000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.206600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.990400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.081000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.901800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.428000E-01
Normal-vs-Daily Drinker
5.787800E-01
Normal-vs-Weekly Drinker
9.736000E-01
Normal-vs-Occasional Drinker
3.540600E-01
Normal-vs-Social Drinker
4.448200E-01
Non Drinker-vs-Daily Drinker
3.035800E-01
Non Drinker-vs-Weekly Drinker
8.134000E-01
Non Drinker-vs-Occasional Drinker
2.120800E-01
Non Drinker-vs-Social Drinker
2.415600E-01
Daily Drinker-vs-Weekly Drinker
3.236400E-01
Daily Drinker-vs-Occasional Drinker
8.344400E-01
Daily Drinker-vs-Social Drinker
8.681400E-01
Weekly Drinker-vs-Occasional Drinker
1.607030E-01
Weekly Drinker-vs-Social Drinker
2.275200E-01
Occasional Drinker-vs-Social Drinker
9.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.002000E-01
Normal-vs-Grade 2
2.632400E-01
Normal-vs-Grade 3
1.304440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.020900E-03
Grade 1-vs-Grade 3
3.086000E-01
Grade 1-vs-Grade 4
3.002000E-01
Grade 2-vs-Grade 3
3.964100E-02
Grade 2-vs-Grade 4
2.632400E-01
Grade 3-vs-Grade 4
1.304440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.346600E-01
Normal-vs-NonDiabetic
9.119400E-01
Diabetic-vs-NonDiabetic
3.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.705600E-01
Normal-vs-NoPancreatitis
8.263600E-01
Pancreatitis-vs-NoPancreatitis
2.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.018000E-01
Normal-vs-N1
8.547800E-01
N0-vs-N1
9.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.533000E-01
Normal-vs-TP53-NonMutant
6.726400E-01
TP53-Mutant-vs-TP53-NonMutant
1.782090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
